home / stock / smfr / smfr message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: $WGS 41% v4,3M c.5050 f798,247M H.52 ML.272 | znewcar1 | investorshangout | 03/20/2023 10:35:44 PM |
$SMFR...MGS..READY TO RUMBLE!! | TrendTrade2016 | investorshub | 01/11/2023 9:10:43 AM |
znewcar1: $SMFR 26% v4,7M c.3106 f386,795M H.3306 ML.22 YL.235 gapNgo | znewcar1 | investorshangout | 01/09/2023 11:02:35 PM |
$SMFR here we go...monster in the making | TrendTrade2016 | investorshub | 01/09/2023 6:10:26 PM |
$SMFR breaking out | TrendTrade2016 | investorshub | 01/09/2023 3:34:29 PM |
Nice DD thank you for your work on | Triple nickle | investorshub | 12/13/2022 3:25:05 PM |
Historic short interest: | XenaLives | investorshub | 05/11/2022 8:25:33 AM |
Historic short interest: | XenaLives | investorshub | 04/14/2022 2:17:46 PM |
Institutional Shares (Long) 119,435,731 - 49.24% (ex 13D/G) - | XenaLives | investorshub | 03/01/2022 2:26:34 PM |
I discovered this company through this PR - | XenaLives | investorshub | 03/01/2022 2:22:22 PM |
News, Short Squeeze, Breakout and More Instantly...
Sema4 Holdings Corp. Company Name:
SMFR Stock Symbol:
NASDAQ Market:
Company expects to exceed 2022 revenue target with strong momentum to deliver continued growth in 2023 combining GeneDx and Centrellis ® platforms Company’s common stock will trade on the Nasdaq under new ticker “WGS” effective January 10, 2023 STAMFO...
STAMFORD, Conn., Dec. 30, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the company will participate in the 41 st Annual J.P. Morgan Healthcare Conference in San Francisco. Katherine Stueland , President and Chief Executive Officer, will del...
STAMFORD, Conn., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the results of a new study on mitochondrial diseases in newborns. The findings support the addition of mitochondrial DNA (mtDNA) testing to rapid exome sequencing, showing it ca...